SpringWorks Therapeutics Inc (SWTX)

37.14 +0.33 (+0.90%) USD  |  NASDAQ  |  Dec 26, 16:00
37.34 +0.20 (+0.54%) After-Hours: 20:00
More

SpringWorks Therapeutics Research and Development Expense (Quarterly): 42.30M for Sept. 30, 2024

Research and Development Expense (Quarterly) Chart

View Research and Development Expense (Quarterly) for SWTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

View Research and Development Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Quarterly) Benchmarks

View Research and Development Expense (Quarterly) Benchmarks
Start Trial
Vertex Pharmaceuticals Inc 875.90M
PTC Therapeutics Inc 161.41M
Blueprint Medicines Corp 85.30M
Edgewise Therapeutics Inc 32.22M
NovaBay Pharmaceuticals Inc 0.004M